New York State Common Retirement Fund Biovie Inc. Transaction History

New York State Common Retirement Fund

  • $73.9 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 31, 2024
SELL
$0.4 - $0.56 $6,880 - $9,632
-17,200 Reduced 99.8%
35 $0
Q3 2023

Nov 07, 2023
BUY
$2.75 - $5.17 $96 - $180
35 Added 0.2%
17,235 $59,000
Q2 2023

Aug 07, 2023
BUY
$4.09 - $8.29 $70,348 - $142,587
17,200 New
17,200 $74,000

Others Institutions Holding BIVI

# of Institutions
5
Shares Held
340K
Call Options Held
0
Put Options Held
0
View Full List

About BIOVIE INC.

BIVI Quotes by TradingView
  • Ticker BIVI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 30,165,300
  • Market Cap $64.3M
  • Description
  • BioVie Inc., a clinical stage biotechnology company, engages in the discovery, development, and commercialization of drugs therapies in the United States. Its products in pipeline include BIV201, which completed Phase IIa clinical trial for the treatment of ascites due to chronic liver cirrhosis; and NE3107, which is in Phase III clinical trial ...
More about BIVI
Track This Portfolio

Track New York State Common Retirement Fund Portfolio

Follow New York State Common Retirement Fund and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on New York State Common Retirement Fund with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email